Atlas Trials

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

Clinical trial NCT01132404 · TERMINATED

Trial details

NCT number
NCT01132404
Sponsor
Millennium Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate CancerProstatic Neoplasms
Start date
2010-11-01
Primary completion
2011-09-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.